Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Subha Madhavan, Clifford Baron

Premium

Personalized Cancer Therapy (Perthera), a company that develops precision cancer drugs, has hired Subha Madhavan, as its chief data officer. Madhavan will head up the planning and organization of Perthera's data analytic framework, standards, and quality control.

Madhavan is director of the Innovation Center for Biomedical Informatics at the Georgetown University Medical Center and leads the biomedical informatics program at the Georgetown-Howard CTSA. She was also principal investigator of the Breast and Colon Cancer Family Registries data center, which collects public health and epidemiology data from twelve sites in the US, Australia, and Canada. She recently partnered with the US Food and Drug Administration on its Center for Excellence in Regulatory Science program, which aims to advance evidence criteria in the areas of pharmacogenomics and vaccine safety.


CollabRx has appointed Clifford Baron as its VP and chief operating officer. Previously Baron was at Accelrys, directing various functions, including biology product marketing, business development, and professional services. He also founded Lexigraphic, a firm consulting biotechnology startups, and was senior director of global solutions at Applied Biosystems.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.